Skip to main content

Animations

MJFF Publications

1601 - 1625 of 9104 Results
Title
Year
  • Year
  • 2024
  • 2021
  • 2018
  • 2026
  • 2019
  • 2017
  • 2011
  • 2026
  • 2025
  • 2021
  • 2026
  • 2026
  • 2014
  • 2013
  • 2014
  • 2012
  • 2013
  • 2018
  • 2020
  • 2019
  • 2019
  • 2014
  • 2019
  • 2021
  • 2017
  • Summary Details
    OPEN
    Title: Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01711-w
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy
    Journal Name: ACS Pharmacology & Translational Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-018-1449-2
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.70672
    Citation Count: 0
  • Summary Details
    OPEN
    Title: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.038596
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Combating Parkinson’s disease-associated toxicity by modulating proteostasis
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1620082114
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/795294
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson’s disease
    Journal Name: Molecular Systems Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s44320-026-00190-0
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70028
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg3092
    Citation Count: 112
  • Summary Details
    OPEN
    Title: fMRI-based deep brain stimulation programming for Parkinson's disease: a blinded, crossover clinical trial
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.brs.2026.103069
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Excess risk of fracture in incident Parkinson’s disease Medicare beneficiaries
    Journal Name: Injury Epidemiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40621-025-00643-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The “Michael Foundation”—A foundation against epilepsy
    Journal Name: Epilepsia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/epi.12509
    Citation Count: 0
  • Disease-modifying therapies for Parkinson's disease
    2013
    Summary Details
    OPEN
    Title: Disease-modifying therapies for Parkinson's disease
    Journal Name: The Biomedical & Life Sciences Collection
    Publisher: Henry Stewart Talks
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.69645/krxj9755
    Citation Count: 0
  • Fox Trial Finder, un nouvel outil pour la recherche clinique
    2014
    Summary Details
    RESTRICTED
    Title: Fox Trial Finder, un nouvel outil pour la recherche clinique
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360
    Citation Count: 0
  • P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    2012
    Summary Details
    RESTRICTED
    Title: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296
    Citation Count: 0
  • No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    2013
    Summary Details
    RESTRICTED
    Title: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187
    Citation Count: 0
  • O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    2018
    Summary Details
    RESTRICTED
    Title: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13021
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088
    Citation Count: 0
  • Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)
    2019
    Summary Details
    RESTRICTED
    Title: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001
    Citation Count: 0
  • Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    2014
    Summary Details
    RESTRICTED
    Title: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016
    Citation Count: 0
  • Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    2019
    Summary Details
    RESTRICTED
    Title: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011
    Citation Count: 0
  • Summary Details
    OPEN
    Title: α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26102
    Citation Count: 25
  • Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    2017
    Summary Details
    RESTRICTED
    Title: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.